The buying on the counter came after Gujarat Themis Biosyn signed an Asset Purchase Agreement with Sanofi to acquire a ...
Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale ...
Gujarat Themis Biosyn Ltd has signed an asset purchase agreement to acquire Sanofi’s global portfolio of 13 anti-tuberculosis and anti-infective branded generics. The deal, subject to antitrust and ...
PARIS — For patients with type 2 diabetes and stable coronary artery disease, the benefits of adding ticagrelor (Brilinta/Brilique, AstraZeneca) to aspirin in terms of reduced ischemic events did not ...
An update from Gujarat Themis Biosyn Ltd ( (IN:GUJTHEM) ) is now available.
Financial firms are spending billions on increasingly onerous compliance rules each year. Themis offers pay-as-you-go risk-management and compliance for banks, fintechs and crypto startups. See the ...
Themis has raised €40 million ($44 million). The Merck-backed series D positions Themis to take its chikungunya vaccine through a phase 3 trial and move the lead candidate from its immuno-oncology R&D ...
5mon
Themis Qi
Themis joined SCMP in 2025 as a business reporter. She previously covered business trends in Hong Kong and mainland China with topics including financial market, EV and new energy. Prior to joining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results